A. Peacock (Clydebank, United Kingdom), R. Naeije (Brussels, Belgium)
Current management of patients with chronic thromboembolic pulmonary hypertension
J. Pepke-Zaba, E. Mayer, M. Delcroix, G. Simonneau, I. Lang (Cambridge, United Kingdom; Bad Nauheim, Germany; Leuven, Belgium; Paris, France; , Austria)
|  |
Prevalence of chronic thrombo-embolic pulmonary hypertension after pulmonary embolism: A prospective multicenter study
O. Sanchez, L. Guérin, F. Couturaud, F. Parent, D. Pontal, G. Simonneau, G. Meyer (Brest, Clamart, France)
|  |
Poor subpleural perfusion as a predictor for a poor outcome in chronic thromboembolic pulmonary hypertension
N. Tanabe, T. Sugiura, S. Sakao, Y. Kasahara, M. Saito, S. Kitazono, T. Jujyo, H. Amano, Y. Takiguchi, M. Masuda, K. Tatsumi (Chiba, Japan)
|  |
Long-term safety and clinical effects of riociguat in chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: Interim analysis of a phase II extension study
H. A. Ghofrani, M. M. Hoeper, M. Halank, F. J. Meyer, G. Staehler, J. Behr, R. Ewert, T. Binnen, G. Weimann, F. Grimminger, on Behalf of the Study Investigators (Hannover, Dresden, Heidelberg, Greifswald, Leverkusen, Wuppertal, Germany)
| |
Efficacy and safety of bosentan in portopulmonary hypertension according to the severity of liver disease
L. Savale, R. Magnier, J. Le Pavec, X. Jaïs, D. O‘Callaghan, D. Montani, D. Natali, M. Humbert, G. Simonneau, O. Sitbon (Clamart, Caen, France)
| |
Non-invasive parameters can predict out of proportion pulmonary hypertension (PH) in conjunction with heart failure and preserved systolic function (HFPSF) in patients with moderate to severe PH
R. Wolff, O. Amir, T. Pesachovitz, I. Lavi, B. Lewis, N. Peled, Y. Adir (Haifa, Israel)
| |
Absence of influence of gender on clinical phenotypes in BMPR2 mutation carriers with pulmonary arterial hypertension from the French registry
B. Girerd, D. Montani, G. Simonnneau, F. Soubrier, M. Humbert (Clamart, Paris, France)
| |
2-year outcomes in newly and previously diagnosed patients with pulmonary arterial hypertension enrolled in REVEAL
A. Frost, D. Badesch, D. Miller, R. Benza, M. McGoon (Houston, Denver, San Francisco, Pittsburgh, Rochester, United States Of America)
| |